![Valeria Cnossen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Posizioni attive di Valeria Cnossen
Società | Posizione | Inizio | Fine |
---|---|---|---|
GALAPAGOS NV | Consigliere Generale | 01/01/2023 | - |
Storia della carriera di Valeria Cnossen
Precedenti posizioni note di Valeria Cnossen
Società | Posizione | Inizio | Fine |
---|---|---|---|
Johnson & Johnson Consumer NV | Corporate Officer/Principal | - | - |
Crucell NV
![]() Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Responsabile della Conformità | - | - |
Consigliere Generale | - | - |
Statistiche
Distribuzione geografica
Belgio | 3 |
Paesi Bassi | 2 |
Posizioni
General Counsel | 2 |
Compliance Officer | 1 |
Corporate Officer/Principal | 1 |
Settori
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
GALAPAGOS NV | Health Technology |
Aziende private | 2 |
---|---|
Crucell NV
![]() Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
Johnson & Johnson Consumer NV |
- Borsa valori
- Insiders
- Valeria Cnossen
- Esperienza